Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 29;12(11):3733.
doi: 10.3390/jcm12113733.

Perinatal Outcomes after Liver Transplantation: Is There a Role for Aspirin Treatment?

Affiliations

Perinatal Outcomes after Liver Transplantation: Is There a Role for Aspirin Treatment?

Gil Zeevi et al. J Clin Med. .

Abstract

Background: We aimed to describe perinatal outcomes and evaluate aspirin treatment effects in liver-transplanted pregnant women.

Methods: A retrospective study examining perinatal outcomes in liver transplant recipients at a single center (2016-2022). The effect of low-dose aspirin treatment on the risk of developing hypertensive disease in these patients was evaluated.

Results: Fourteen deliveries in 11 pregnant liver transplant recipients were identified. Primary liver disease was Wilson's in 50% of pregnancies. The median age was 23 years at transplant and 30 at conception. Tacrolimus was administered in all, steroids in 10 (71.43%), and aspirin (100 mg daily) in 7 (50.0%). Overall, two women (14.28%) developed preeclampsia, and one (7.14%) developed gestational hypertension. Median gestational age at delivery was 37 weeks (31-39 weeks), with six preterm births (between 31-36 weeks) and a median birthweight of 3004 g(range 1450-4100 g). None of those receiving aspirin developed hypertensive disease or suffered excessive bleeding during pregnancy, compared to two (28.57%) with pre-eclampsia in the non-aspirin group.

Conclusion: Liver-transplanted pregnant women comprise a unique and complex patient population with overall favorable pregnancy outcomes. Based on our single-center experience and due to its safety profile and potential benefit, we recommend low-dose aspirin in all liver transplanted patients during pregnancy for preeclampsia prevention. Further large prospective studies are needed to corroborate our findings.

Keywords: aspirin; liver transplantation; perinatal outcomes; pre-eclampsia; prevention.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Coffin C.S., Shaheen A.A.M., Burak K.W., Myers R.P. Pregnancy outcomes among liver transplant recipients in the United States: A nationwide case-control analysis. Liver Transplant. 2009;16:56–63. doi: 10.1002/lt.21906. - DOI - PubMed
    1. Alisi A., Balsano C., Bernabucci V., Berzigotti A., Brunetto M., Bugianesi E., Burra P., Calvaruso V., Cariani E., Coco B., et al. AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the liver (AISF) Dig. Liver Dis. 2016;48:860–868. doi: 10.1016/j.dld.2016.04.009. - DOI - PubMed
    1. Kubo S., Uemoto S., Furukawa H., Umeshita K., Tachibana D., Japanese Liver Transplantation Society Pregnancy outcomes after living donor liver transplantation: Results from a Japanese survey. Liver Transplant. 2014;20:576–583. doi: 10.1002/lt.23837. - DOI - PubMed
    1. Kanzaki Y., Kondoh E., Kawasaki K., Mogami H., Chigusa Y., Konishi I. Pregnancy outcomes in liver transplant recipients: A 15-year single-center experience. J. Obstet. Gynaecol. Res. 2016;42:1476–1482. doi: 10.1111/jog.13096. - DOI - PubMed
    1. Di Girolamo R., Alameddine S., Khalil A., Santilli F., Rizzo G., Maruotti G.M., Liberati M., D’Antonio F. Clinical practice guidelines on the use of aspirin in pregnancy: Systematic review. Eur. J. Obstet. Gynecol. Reprod. Biol. 2023;282:64–71. doi: 10.1016/j.ejogrb.2022.12.032. - DOI - PubMed

LinkOut - more resources